LATEST NEWS
For a full overview of our announcements and press releases, visit our Euronext Oslo Børs Newsweb (Link)
EXACT Therapeutics announces first half 2023 interim results
EXACT Therapeutics announces appointment of Caspar Foghsgaard as SVP Commercial & Business Development
EXACT Therapeutics announces positive clinical results from the ACTIVATE Phase I dose escalation
Invitation to first half results 2023 presentation of EXACT Therapeutics AS
Wall Street Journal:
New Ultrasound Therapy Could Help Treat Alzheimer’s, Cancer

